FI822770A0 - Bensazepin-2-oner, foerfarande foer deras framstaellning, farmaceutiska preparat innehaollande dessa foereningar samt deras terapeutiska anvaendning - Google Patents

Bensazepin-2-oner, foerfarande foer deras framstaellning, farmaceutiska preparat innehaollande dessa foereningar samt deras terapeutiska anvaendning

Info

Publication number
FI822770A0
FI822770A0 FI822770A FI822770A FI822770A0 FI 822770 A0 FI822770 A0 FI 822770A0 FI 822770 A FI822770 A FI 822770A FI 822770 A FI822770 A FI 822770A FI 822770 A0 FI822770 A0 FI 822770A0
Authority
FI
Finland
Prior art keywords
deras
bensazepin
anvaendning
oner
therapeutic
Prior art date
Application number
FI822770A
Other languages
English (en)
Other versions
FI76074B (fi
FI822770L (fi
FI76074C (fi
Inventor
Jeffrey W H Watthey
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI822770A0 publication Critical patent/FI822770A0/fi
Publication of FI822770L publication Critical patent/FI822770L/fi
Publication of FI76074B publication Critical patent/FI76074B/fi
Application granted granted Critical
Publication of FI76074C publication Critical patent/FI76074C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI822770A 1981-08-11 1982-08-09 Foerfarande foer framstaellning av antihypertensiva 3-amino-/1/bensazepin-2-on-1-alkansyror. FI76074C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US29190781A 1981-08-11 1981-08-11
US29190781 1981-08-11
US31986381A 1981-11-09 1981-11-09
US31986381 1981-11-09

Publications (4)

Publication Number Publication Date
FI822770A0 true FI822770A0 (fi) 1982-08-09
FI822770L FI822770L (fi) 1983-02-12
FI76074B FI76074B (fi) 1988-05-31
FI76074C FI76074C (fi) 1988-09-09

Family

ID=26967047

Family Applications (1)

Application Number Title Priority Date Filing Date
FI822770A FI76074C (fi) 1981-08-11 1982-08-09 Foerfarande foer framstaellning av antihypertensiva 3-amino-/1/bensazepin-2-on-1-alkansyror.

Country Status (22)

Country Link
EP (1) EP0072352B1 (fi)
KR (3) KR890003425B1 (fi)
AR (3) AR240806A1 (fi)
AT (1) ATE18397T1 (fi)
AU (1) AU561395B2 (fi)
CA (1) CA1196636A (fi)
CY (1) CY1403A (fi)
DD (1) DD202546A5 (fi)
DE (1) DE3269625D1 (fi)
DK (1) DK157881C (fi)
ES (6) ES514856A0 (fi)
FI (1) FI76074C (fi)
GB (1) GB2103614B (fi)
GR (1) GR77256B (fi)
HK (1) HK93387A (fi)
HU (1) HU189628B (fi)
IE (1) IE53668B1 (fi)
IL (1) IL66501A (fi)
NL (1) NL930112I2 (fi)
NO (1) NO161558C (fi)
NZ (1) NZ201555A (fi)
PT (1) PT75395B (fi)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3242599A1 (de) * 1982-11-18 1984-05-24 Dr. Karl Thomae Gmbh, 7950 Biberach Neue benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel
US4473575A (en) * 1982-07-19 1984-09-25 Ciba-Geigy Corporation 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
DE3373469D1 (en) * 1982-09-30 1987-10-15 Merck & Co Inc 1-n-alkylcarboxy-benzofused lactams useful as antihypertensive agents
US4575503A (en) * 1983-02-10 1986-03-11 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4564612A (en) * 1983-04-22 1986-01-14 Takeda Chemical Industries, Ltd. Condensed, seven-membered ring compounds and their use
US4539150A (en) * 1983-06-29 1985-09-03 Mitsui Toatsu Chemicals, Inc. Benzothiazepine derivatives and their methods of preparation
JPS608284A (ja) * 1983-06-29 1985-01-17 Mitsui Toatsu Chem Inc ベンゾチアゼピン誘導体およびその製造法
IL72523A (en) * 1983-08-12 1988-06-30 Takeda Chemical Industries Ltd 3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine derivatives,their production and pharmaceutical compositions containing them
AU570710B2 (en) * 1983-08-12 1988-03-24 Takeda Chemical Industries Ltd. 4-oxo-2, 3, 4, 5-tetrahydro-1, 5-benzoxazepine derivatives
US4638000A (en) * 1983-08-12 1987-01-20 Takeda Chemical Industries, Ltd. Condensed seven-membered ring compounds, their production and use
CA1266647A (en) * 1984-06-26 1990-03-13 William H. Parsons Benzofused lactams useful as antihypertensive agents and as cholecystokinin antagonists
DE3586445T2 (de) * 1984-06-26 1993-01-14 Merck & Co Inc Kondensierte benzo-laktam-verbindungen und deren pharmazeutische zusammensetzungen.
EP0166357A3 (en) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzofused lactams and pharmaceutical compositions containing them
US4785089A (en) * 1985-06-13 1988-11-15 Ciba-Geigy Corporation Novel sulfonic acid esters and their preparation
DE3704661A1 (de) * 1987-02-14 1988-08-25 Hoechst Ag Annelierte azepinon- und azocinon-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung, sowie zwischenprodukte bei ihrer herstellung
EP0322779A3 (en) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Benzolactam compounds and pharmaceutical uses thereof
TW197945B (fi) * 1990-11-27 1993-01-11 Hoechst Ag
GB9100028D0 (en) * 1991-01-02 1991-02-20 Ici Plc Compounds
GB9212308D0 (en) * 1992-06-10 1992-07-22 Ici Plc Therapeutic compositions
US5504080A (en) * 1992-10-28 1996-04-02 Bristol-Myers Squibb Co. Benzo-fused lactams
EP0673371A1 (de) * 1992-12-11 1995-09-27 Novartis AG Benzazepinon-derivate
GB9310075D0 (en) * 1993-05-17 1993-06-30 Fujisawa Pharmaceutical Co New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
GB9311948D0 (en) * 1993-06-10 1993-07-28 Zeneca Ltd Substituted nitrogen heterocycles
US5801168A (en) * 1994-06-09 1998-09-01 Zeneca Limited Substituted nitrogen heterocycles
US5597922A (en) * 1994-07-29 1997-01-28 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Glycine receptor antagonist pharmacophore
AU784646B2 (en) * 1999-11-18 2006-05-18 Antexpharma, Inc. Substituted 1-benzazepines and derivatives thereof
CA2668823A1 (en) 2000-12-27 2002-07-04 Merck Patent Gesellschaft Mit Beschraenkter Haftung Process for the preparation of .alpha.-aminosubstituted carboxylic acid amides
US6919450B2 (en) 2001-03-27 2005-07-19 Ranbaxy Laboratories Limited Process for the preparation of benazepril
EP1443919A4 (en) 2001-11-16 2006-03-22 Bristol Myers Squibb Co DOUBLE INHIBITORS OF THE FATTY ACID BINDING PROTEIN OF THE ADIPOCYTES AND THE FATTY ACID BINDING PROTEIN OF KERATINOCYTES
JP2006500337A (ja) * 2002-07-26 2006-01-05 チバ　スペシャルティ　ケミカルズ　ホールディング　インコーポレーテッド 塩酸ベナゼプリルの結晶多形形態および非晶質形態
KR100710548B1 (ko) * 2002-12-26 2007-04-24 에스케이 주식회사 (ｓ)-3-아미노-2,3,4,5-테트라히드로-2-옥소-1Ｈ-1-벤자제핀-1-아세트산 및 이의 에스테르 화합물의 제조방법
US7459474B2 (en) 2003-06-11 2008-12-02 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US8080579B2 (en) 2005-10-03 2011-12-20 The Regents Of The University Of Michigan Compositions and methods for treatment of inflammatory bowel disease
US7592461B2 (en) 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
EP2099767A1 (en) 2006-11-01 2009-09-16 Brystol-Myers Squibb Company Modulators of glucocorticoid receptor, ap-1, and/or nf- b activity and use thereof
WO2008057862A2 (en) 2006-11-01 2008-05-15 Bristol-Myers Squibb Company MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF
JP5546451B2 (ja) 2007-06-04 2014-07-09 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸の障害、炎症、癌および他の障害の処置に有用なグアニル酸シクラーゼのアゴニスト
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US7828840B2 (en) 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
AU2009256157B2 (en) 2008-06-04 2014-12-18 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2009158380A1 (en) 2008-06-24 2009-12-30 Bristol-Myers Squibb Company Cyclopentathiophene modulators of the glucocorticoid receptor, ap-1, and/or nf-kappa b activity and use thereof
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
WO2015027021A1 (en) 2013-08-22 2015-02-26 Bristol-Myers Squibb Company Imide and acylurea derivatives as modulators of the glucocorticoid receptor
CN113292495B (zh) * 2021-06-18 2022-09-13 迪嘉药业集团有限公司 一种 (s)-氨基化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395150A (en) * 1965-02-26 1968-07-30 Squibb & Sons Inc Benzothiazepine carboxamides and derivatives thereof
GB1305278A (fi) * 1970-03-12 1973-01-31

Also Published As

Publication number Publication date
CA1196636A (en) 1985-11-12
EP0072352B1 (de) 1986-03-05
FI76074B (fi) 1988-05-31
DK358682A (da) 1983-02-12
AR240807A2 (es) 1991-02-28
AR240806A2 (es) 1991-02-28
NL930112I1 (nl) 1993-10-18
DE3269625D1 (en) 1986-04-10
GR77256B (fi) 1984-09-11
HU189628B (en) 1986-07-28
CY1403A (en) 1987-12-18
AR240807A1 (es) 1991-02-28
FI822770L (fi) 1983-02-12
IL66501A (en) 1987-10-20
PT75395A (en) 1982-09-01
ES526889A0 (es) 1986-02-01
AU8701482A (en) 1983-05-12
ES8504728A1 (es) 1985-04-16
FI76074C (fi) 1988-09-09
DK157881C (da) 1990-07-23
GB2103614B (en) 1984-11-21
KR900001190B1 (ko) 1990-02-28
NO822722L (no) 1983-02-14
EP0072352A1 (de) 1983-02-16
AR240806A1 (es) 1991-02-28
DD202546A5 (de) 1983-09-21
ES8604523A1 (es) 1986-02-01
ES526888A0 (es) 1985-04-16
IE821929L (en) 1983-02-11
ES530658A0 (es) 1985-12-01
NZ201555A (en) 1986-06-11
KR840001139A (ko) 1984-03-28
ES8601142A1 (es) 1985-11-01
KR900001191B1 (ko) 1990-02-28
NO161558B (no) 1989-05-22
AR241222A1 (es) 1992-02-28
NL930112I2 (nl) 1996-11-01
KR890003425B1 (ko) 1989-09-20
NO161558C (no) 1989-08-30
DK157881B (da) 1990-02-26
ES8502974A1 (es) 1985-02-01
IL66501A0 (en) 1982-12-31
ES8606285A1 (es) 1986-04-16
IE53668B1 (en) 1989-01-04
ES8602682A1 (es) 1985-12-01
ES514856A0 (es) 1985-02-01
HK93387A (en) 1987-12-18
AU561395B2 (en) 1987-05-07
ES526886A0 (es) 1985-11-01
PT75395B (en) 1985-11-15
GB2103614A (en) 1983-02-23
ES526887A0 (es) 1986-04-16
ATE18397T1 (de) 1986-03-15

Similar Documents

Publication Publication Date Title
FI822770A0 (fi) Bensazepin-2-oner, foerfarande foer deras framstaellning, farmaceutiska preparat innehaollande dessa foereningar samt deras terapeutiska anvaendning
FI801876A (fi) Farmaceutiska preparat
FI860559A0 (fi) 11 -fenyl-gonaner, deras framstaellning och dessa innehaollande farmaceutiska preparat.
ATE22007T1 (de) Pharmazeutische mischung.
FI821197L (fi) Terapeutiska aemnen
NO166391C (no) Preparat for motvirkning av daarlig aande.
FI873630A (fi) Stabilt farmaceutiskt preparat.
IT8247937A0 (it) Polipeptedi, loro preparazione eloro impiego come medicamenti
FI820983L (fi) Acyl-kinolinonderivat, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska preparat samt deras anvaendning
FI822187A0 (fi) Farmaceutiska preparat
FI890488A (fi) Vaextextrakt innehaollande farmaceutiska preparat samt foerfarande foer framstaellning daerav.
FI823217L (fi) Aminopropanolderivat av 2-hydroxi- -fenylpropiofenoner, foerfaranden foer deras framstaellning ochdessa innehaollande terapeutiska medel
FI820877L (fi) Nya tiazolderivat, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska preparat och deras anvaendning
FI874382A (fi) Farmaceutiska preparat.
FI882965A (fi) Aminocyklopentyletrar och deras framstaellning och farmaceutiska preparat.
FI834138A0 (fi) Heterocyklylfoereningar, dessa foereningar innehaollande farmaceutiska preparat samt deras anvaendning
FI810874L (fi) Farmaceutiska preparat
FI823304L (fi) Amino-oxazolylfoereningar, foerfarande foer deras framstaellning, dessa foereningar innehaollande farmaceutiska preparat samt anvaendning av de sistnaemnda
FI883747A0 (fi) Topiskt anvaendbara farmaceutiska preparat.
FI812536L (fi) Nya diaryl-imidazol-foereningar foerfaranden foer deras framstaellning dessa foereningar innehaollande farmaceutiska preparat samt deras anvaendning
FI823690A0 (fi) Aminocyklopentanestrar och deras framstaellning och farmaceutiska preparat
FI834140A0 (fi) Heterocyklyltiofoereningar, dessa foereningar innehaollande farmaceutiska preparat samt deras anvaendning
NL193821B (nl) Farmaceutisch preparaat.
FI824170A0 (fi) Imidazobensodiazepiner, foerfarande foer deras framstaellning, dessa foereningar innehaollande farmaceutiska preparat och deras anvaendning
NO830294L (no) Medikamentinhalator.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MA Patent expired

Owner name: NOVARTIS AG